Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?

Annals of Internal Medicine

Volumn 136, Issue 1, 2002, Pages 76-78

  Pincus, T ^a   Sokka, T ^a   Stein, C M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISONE;

ARTHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SHORT SURVEY; STEROID THERAPY; TABLET FORMULATION; TREATMENT OUTCOME;

EID: 0036137296     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-1-200201010-00013     Document Type: Short Survey

References (20)

1. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticostetone; compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis
2. A comparison of cortisone and aspirin in the treatment of early cases of theumatoid arthritis
3. Major undesirable side-effects resulting from prednisolone and prednisone
4. Progression of radiological changes in rheumatoid arthritis
5. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years
6. Low dose prednisone therapy in rheumatoid arthritis: A double blind study
7. The effect of glucocorticoids on joint destruction in rheumatoid arthritis
8. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures
9. The mortality of rheumatoid arthritis
10. Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study
11. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone
12. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: Clinical efficacy, disease-modifying properties, and side effects. A randomized, double-blind, placebo-controlled clinical trial
13. Placebo-controlled studies in rheumatoid arthritis: Ethical issues
14. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: A pteventive strategy
15. Should steroids be used in the management of rheumatoid arthritis?
16. Low-dose corticosteroids in rheumatoid arthritis. A meta-analysis of their moderate-term effectiveness
17. The stress response and the regulation of inflammatory disease
18. Steroids in rheumatoid arthritis: The honeymoon revisited
19. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies
20. Taking mortality in rheumatoid arthritis seriously-predictive markers, socioeconomic status and comorbidity